You are here

MediShield changes won't cure cost, supply woes

THE MediShield Life Review Committee's key recommendations should go some way towards expanding and improving Singapore's national health insurance system, but the two challenges of supply and cost will continue to be pressing.

The latest comprehensive revision of MediShield Life includes...

Market voices on: